Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon in skin diseases].

M Niimura

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Interferon therapy shows significant effectiveness in treating viral skin diseases like warts, with over 81% response rates. Further research is needed to optimize interferon for common use in dermatology.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnostic criteria for schwannomatosis.

    Neurology·2005
    Same author

    Changes in phosphorylation of the NMDA receptor in the rat hippocampus induced by status epilepticus.

    Journal of neurochemistry·2005
    Same author

    A case of galactosialidosis.

    The British journal of dermatology·2003
    Same author

    A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft.

    The British journal of dermatology·2002
    Same author

    Measurement of absolute cross sections for excitation of the 3s(2)3p(5) 2P(o)(3/2)- 3s(2)3p(5) 2P(o)(1/2) fine-structure transition in Fe9+.

    Physical review letters·2002
    Same author

    Prolonged herpes zoster in a patient infected with the human immunodeficiency virus.

    The Journal of dermatology·2002
    Same journal

    [A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Recent Advances in the Treatment of HER2-Altered Solid Tumors].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [BRAF-Mutant Solid Tumor].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Virology
    • Immunology

    Background:

    • Interferon is utilized in clinical trials for viral skin conditions and malignant skin tumors.
    • Previous studies indicate promising results for interferon in treating viral warts, herpes simplex, and herpes zoster.

    Purpose of the Study:

    • To evaluate the efficacy of interferon therapy in treating viral skin diseases.
    • To assess the effectiveness of intralesional human fibroblast interferon in common warts.
    • To explore the need for further placebo-controlled, double-blind trials for interferon in herpes zoster, especially in immunocompromised patients.

    Main Methods:

    • A double-blind trial involving patients with bilateral common warts of the extremities.
    • Weekly intralesional injections of either human fibroblast interferon or placebo were administered.

    Related Experiment Videos

  • Clinical observations and response rates were recorded for both treatment and placebo groups.

    • Main Results:

    • Over 81% of interferon-treated extremities showed a cure or effective response to therapy.
    • Only 17% of placebo-treated extremities responded to the therapy.
    • Interferon demonstrated significant efficacy in treating common warts compared to placebo.

    Conclusions:

    • Interferon is effective for treating common warts, though its application method may limit routine use to selected patients.
    • Further development of delivery systems or dosage modifications could enhance interferon's value for warts.
    • While interferon appears effective for herpes zoster, further placebo-controlled, double-blind studies are necessary to confirm its efficacy, particularly in immunocompromised individuals.